Does the Addition of Growth Hormone to the Invitro Fertilization/ Intracytoplasmic Sperm Injection Antagonist Protocol Improve Outcome in Poor Responders? A Randomized Controlled Trial
Phase of Trial: Phase IV
Latest Information Update: 13 Aug 2015
Price : $35 *
At a glance
- Drugs Somatrogon (Primary) ; Gonadotropin releasing hormone inhibitors; Menotropin
- Indications Female infertility
- Focus Therapeutic Use
- 06 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Mar 2015 Planned End Date changed from 1 Apr 2015 to 1 Jul 2015, as reported by ClinicalTrials.gov.
- 24 Mar 2015 Planned primary completion date changed from 1 Apr 2015 to 1 Jul 2015, as reported by ClinicalTrials.gov.